Devyser Diagnostics AB Financial Flexibility Index
Devyser Diagnostics AB financial flexibility index. Devyser Diagnostics AB (DVYSR) has a Financial Flexibility Index of 0.24x as of June 2026. Free cash flow of Skr26.70 Million (operating CF Skr12.30 Million minus capex Skr14.40 Million) represents 0% of total liabilities (Skr112.10 Million). See Devyser Diagnostics AB free cash flow efficiency to measure how efficiently the company converts operating cash flow to free cash.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Devyser Diagnostics AB (2018–2025)
Financial flexibility index of Devyser Diagnostics AB from 2018 to 2025. Historical Financial Flexibility Index trend for Devyser Diagnostics AB across 8 annual periods. Check DVYSR cash to earnings ratio to evaluate the quality of earnings relative to operating cash generation.
Devyser Diagnostics AB Financial Flexibility Index by Year (2018–2025)
Devyser Diagnostics AB financial flexibility index by year from 2018 to 2025. Year-by-year free cash flow to debt coverage for Devyser Diagnostics AB. For the full cash flow conversion analysis, see Devyser Diagnostics AB operating cash flow efficiency.
| Year | Flexibility Index | Free Cash Flow (SEK) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.08x | Skr9.70 Million | Skr8.20 Million | Skr115.40 Million | ▼ -65.1% |
| 2024 | 0.24x | Skr30.10 Million | Skr-46.80 Million | Skr124.80 Million | ▲ +180.0% |
| 2023 | -0.30x | Skr-37.70 Million | Skr-69.70 Million | Skr125.00 Million | ▼ -41.9% |
| 2022 | -0.21x | Skr-14.70 Million | Skr-40.50 Million | Skr69.19 Million | ▼ -11.1% |
| 2021 | -0.19x | Skr-7.68 Million | Skr-16.48 Million | Skr40.18 Million | ▼ -306.2% |
| 2020 | 0.09x | Skr4.04 Million | Skr627.00K | Skr43.58 Million | ▼ -85.8% |
| 2019 | 0.65x | Skr23.94 Million | Skr14.63 Million | Skr36.69 Million | ▲ +7.5% |
| 2018 | 0.61x | Skr11.08 Million | Skr6.02 Million | Skr18.25 Million | — |